Journey Medical Corporation Statistics
Share Statistics
Journey Medical Corporation has 20.89M shares outstanding. The number of shares has increased by 12.87% in one year.
| Shares Outstanding | 20.89M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0.78% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 14.31M |
| Failed to Deliver (FTD) Shares | 4 |
| FTD / Avg. Volume | 0% |
Short Selling Information
The latest short interest is 66.93K, so 0.32% of the outstanding shares have been sold short.
| Short Interest | 66.93K |
| Short % of Shares Out | 0.32% |
| Short % of Float | 0.47% |
| Short Ratio (days to cover) | 0.62 |
Valuation Ratios
The PE ratio is -27.26 and the forward PE ratio is -90.83.
| PE Ratio | -27.26 |
| Forward PE | -90.83 |
| PS Ratio | 1.33 |
| Forward PS | 0.9 |
| PB Ratio | 5.16 |
| P/FCF Ratio | 437.58 |
| PEG Ratio | n/a |
Enterprise Valuation
Journey Medical Corporation has an Enterprise Value (EV) of 95.31M.
| EV / Earnings | -24.74 |
| EV / Sales | 1.2 |
| EV / EBITDA | 49.61 |
| EV / EBIT | -45.98 |
| EV / FCF | 397.12 |
Financial Position
The company has a current ratio of 1.35, with a Debt / Equity ratio of 0.87.
| Current Ratio | 1.35 |
| Quick Ratio | 1.1 |
| Debt / Equity | 0.87 |
| Total Debt / Capitalization | 46.41 |
| Cash Flow / Debt | 0.3 |
| Interest Coverage | -1.22 |
Financial Efficiency
Return on equity (ROE) is -0.19% and return on capital (ROIC) is -5.78%.
| Return on Equity (ROE) | -0.19% |
| Return on Assets (ROA) | -0.05% |
| Return on Capital (ROIC) | -5.78% |
| Revenue Per Employee | 1.93M |
| Profits Per Employee | -93.98K |
| Employee Count | 41 |
| Asset Turnover | 1.03 |
| Inventory Turnover | 2.61 |
Taxes
| Income Tax | 221.00K |
| Effective Tax Rate | -0.06 |
Stock Price Statistics
The stock price has increased by -28.68% in the last 52 weeks. The beta is 0.92, so Journey Medical Corporation's price volatility has been higher than the market average.
| Beta | 0.92 |
| 52-Week Price Change | -28.68% |
| 50-Day Moving Average | 4.99 |
| 200-Day Moving Average | 4.87 |
| Relative Strength Index (RSI) | 28.45 |
| Average Volume (20 Days) | 112.02K |
Income Statement
In the last 12 months, Journey Medical Corporation had revenue of 79.18M and earned -3.85M in profits. Earnings per share was -0.21.
| Revenue | 79.18M |
| Gross Profit | 52.52M |
| Operating Income | -2.07M |
| Net Income | -3.85M |
| EBITDA | 1.92M |
| EBIT | -2.07M |
| Earnings Per Share (EPS) | -0.21 |
Balance Sheet
The company has 27.44M in cash and 17.73M in debt, giving a net cash position of 9.71M.
| Cash & Cash Equivalents | 27.44M |
| Total Debt | 17.73M |
| Net Cash | 9.71M |
| Retained Earnings | -72.36M |
| Total Assets | 64.04M |
| Working Capital | 12.83M |
Cash Flow
In the last 12 months, operating cash flow was 5.24M and capital expenditures -5.00M, giving a free cash flow of 240.00K.
| Operating Cash Flow | 5.24M |
| Capital Expenditures | -5.00M |
| Free Cash Flow | 240.00K |
| FCF Per Share | 0.01 |
Margins
Gross margin is 66.33%, with operating and profit margins of -2.62% and -4.87%.
| Gross Margin | 66.33% |
| Operating Margin | -2.62% |
| Pretax Margin | -4.59% |
| Profit Margin | -4.87% |
| EBITDA Margin | 2.43% |
| EBIT Margin | -2.62% |
| FCF Margin | 0.3% |
Dividends & Yields
DERM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -5.63% |
| FCF Yield | 0.31% |
Analyst Forecast
The average price target for DERM is $9, which is 141.3% higher than the current price. The consensus rating is "Buy".
| Price Target | $9 |
| Price Target Difference | 141.3% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
Scores
| Altman Z-Score | -0.61 |
| Piotroski F-Score | 1 |